about
Cell-based small-molecule compound screen identifies fenretinide as potential therapeutic for translocation-positive rhabdomyosarcomaRetinoic acid actions through mammalian nuclear receptors.Generic isotretinoin: a new risk for unborn childrenCombination of 13-Cis retinoic acid and lovastatin: marked antitumor potential in vivo in a pheochromocytoma allograft model in female athymic nude miceMicroRNA involvement in the pathogenesis of neuroblastoma: potential for microRNA mediated therapeutics.Intermittent hypoxia regulates stem-like characteristics and differentiation of neuroblastoma cells.Combination of N-(4-hydroxyphenyl) retinamide and genistein increased apoptosis in neuroblastoma SK-N-BE2 and SH-SY5Y xenograftsAntagonism of cytotoxic chemotherapy in neuroblastoma cell lines by 13-cis-retinoic acid is mediated by the antiapoptotic Bcl-2 family proteinsRetinoids in cancer therapy and chemoprevention: promise meets resistance.Effects of all-trans retinoic acid (ATRA) on human myeloma cells.The interplay between microRNAs and the neurotrophin receptor tropomyosin-related kinase C controls proliferation of human neuroblastoma cells.Redox balance influences differentiation status of neuroblastoma in the presence of all-trans retinoic acidBryostatin-1, Fenretinide and 1α,25 (OH)(2)D(3) Induce Growth Inhibition, Apoptosis and Differentiation in T and B Cell-Derived Acute Lymphoblastic Leukemia Cell Lines (CCRF-CEM and Nalm-6)In vitro and in vivo effects of easily administered, low-toxic retinoid and phenylacetate compounds on human neuroblastoma cellsAlterations in neuroblastoma ganglioside synthesis by induction of GD1b synthase by retinoic acid.Dihydroceramide accumulation and reactive oxygen species are distinct and nonessential events in 4-HPR-mediated leukemia cell death.Preclinical Evaluation of UAB30 in Pediatric Renal and Hepatic MalignanciesPre-Clinical Evaluation of rHDL Encapsulated Retinoids for the Treatment of Neuroblastoma.Efficacy and safety of topical tazarotene: a review.Therapeutic targeting of miRNAs in neuroblastoma.Retinoids in pediatric onco-hematology: the model of acute promyelocytic leukemia and neuroblastoma.Children's Oncology Group's 2013 blueprint for research: neuroblastoma.Factors involved in CLL pathogenesis and cell survival are disrupted by differentiation of CLL B-cells into antibody-secreting cells.Lineage factors and differentiation states in lung cancer progression.All-trans-retinoic acid induces manganese superoxide dismutase in human neuroblastoma through NF-kappaB.Clinical development of fenretinide as an antineoplastic drug: Pharmacology perspectives.N-(4-hydroxyphenyl)retinamide inhibits breast cancer cell invasion through suppressing NF-KB activation and inhibiting matrix metalloproteinase-9 expression.Retinoic acid induces REST degradation and neuronal differentiation by modulating the expression of SCF(β-TRCP) in neuroblastoma cells.On the role of transforming growth factor-beta in the growth inhibitory effects of retinoic acid in human pancreatic cancer cells.All-trans-retinoic acid inhibits collapsin response mediator protein-2 transcriptional activity during SH-SY5Y neuroblastoma cell differentiation.The ATRA-induced differentiation of medulloblastoma cells is enhanced with LOX/COX inhibitors: an analysis of gene expression.Effect of YAP Inhibition on Human Leukemia HL-60 Cells.Pharmacokinetics of the time-dependent elimination of all-trans-retinoic acid in rats.Expression of URG4/URGCP, Cyclin D1, Bcl-2, and Bax genes in retinoic acid treated SH-SY5Y human neuroblastoma cells.YAPping about differentiation therapy in muscle cancer.Ceramide signaling in fenretinide-induced endothelial cell apoptosis.Retinoic acid receptors and tissue-transglutaminase mediate short-term effect of retinoic acid on migration and invasion of neuroblastoma SH-SY5Y cells.
P2860
Q28485302-C9C395C2-C72B-48F7-BBB7-BA9D8FD753F9Q30408649-554F4325-0249-4746-B1FF-38ECF68AEB62Q33555182-CCB41753-64F8-4933-8AF6-66E89B6FDF51Q33765524-F8002F47-E7D9-4251-B30C-1C89FCA36874Q34155009-1E095A09-3F9F-4DC9-9C00-EDD82FDBD9FDQ34170335-1F9CA35A-BB26-4E6D-B259-535051EBAC6FQ35013107-3E1E7903-D115-4B3E-A2AE-4EBE74C9FD68Q35238042-724F74E2-1EA2-4F64-9367-BEBB6E5AD5BFQ35567239-3EA8F992-BC5C-465E-B5B1-F69B3A65A671Q35614620-A4E86B98-8BA6-4B38-8950-45272673781FQ35808837-B29AAB85-0BCC-45D2-B0DC-C93C2BB1E45FQ36382473-0E45AFDC-E552-4AF0-8C4B-C6D610D94629Q36571416-77A46D62-3A4B-4D46-912D-9554C52ED3A8Q36670895-1A05249F-82B2-4B68-AFB7-EF5BC9306886Q36695336-33B86848-A868-4E0E-BDCE-43AF4B580D07Q36874463-41FB67E4-BB03-4C48-B74F-6C4DA9B3E477Q36917809-C35AEFCF-695C-41E3-A5D1-77AD1FF75D31Q37475635-2AED8EEE-41BE-4936-A19D-31962EC293CFQ37705240-DE547C1F-4C5C-4BA2-8206-5963042A8150Q37775637-81A40E68-93D6-4041-8943-C8D1E07A190BQ38039970-91BE6587-3483-4950-8536-BAB91918F897Q38068818-FAC94AF9-9750-4EB2-97AE-154D2CB08018Q38298483-FEC835A5-15AB-446F-8F56-B121D24AC5A6Q38395972-F3E53005-4882-4040-B4CF-43724BEEE556Q38663096-38F270A7-338F-4065-A4DD-AB6FA164DDD1Q39254280-74050556-7A81-44A8-8768-D1907B52F97FQ39367242-115BD555-76E0-4D2B-B6E3-20D2DE622562Q39552254-60DF9001-2856-4DF8-B4E5-18805421C1D8Q40031262-DD80C27E-1E0B-4EBC-A7A2-BDB63066209DQ40182379-DEC961DB-77CA-4BE3-A31D-EA8BA39B8AF7Q40999604-CE78460E-D557-4ACF-A2B1-6DE05B3993FEQ41455333-7518DBD5-0FC9-4A4E-A294-720BBBE00543Q41854221-30C659BD-CDD0-45AD-A330-BAC609793617Q41976538-0DE7574B-4476-4248-ACC5-E5314689048BQ42062946-F861F411-7F3E-4743-9ABE-8F68226005DAQ44185922-077FD7D5-E370-40B5-8855-1F6744E1B863Q46699463-5F95A0E5-3A69-47BF-88F3-E17C2E8CC17B
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Retinoid therapy of childhood cancer.
@ast
Retinoid therapy of childhood cancer.
@en
Retinoid therapy of childhood cancer.
@nl
type
label
Retinoid therapy of childhood cancer.
@ast
Retinoid therapy of childhood cancer.
@en
Retinoid therapy of childhood cancer.
@nl
prefLabel
Retinoid therapy of childhood cancer.
@ast
Retinoid therapy of childhood cancer.
@en
Retinoid therapy of childhood cancer.
@nl
P1476
Retinoid therapy of childhood cancer
@en
P2093
R S Lemons
P304
P356
10.1016/S0889-8588(05)70256-2
P50
P577
2001-10-01T00:00:00Z